New gel could help heal wounds in rare skin disease

NCT ID NCT06917690

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a gel called Oleogel-S10 on skin wounds in people with inherited epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. The trial includes 6 Japanese children and adults with junctional or dystrophic EB. Participants apply the gel to wounds every few days for 45 days, with follow-up visits every two weeks. The goal is to see if the gel helps wounds close faster and is safe to use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Oleogel-S10 (a topical gel)
What this could lead to
If successful, this gel could become a treatment option to help close and heal skin wounds in people with epidermolysis bullosa, reducing pain and infection risk.
What could go wrong
This is a small, early-phase trial with only 6 participants, so results may not apply to everyone. The gel may not work for all wound types, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLLAGEN DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fukuoka Children's Hospital - Dermatology

    RECRUITING

    Fukuoka, Japan

  • Hokkaido University Hospital

    RECRUITING

    Sapporo, Japan

  • Kobe University Hospital

    RECRUITING

    Kobe, Japan

  • Kurume University Hospital

    RECRUITING

    Fukuoka, Japan

  • Niigata University Medical and Dental Hospital

    RECRUITING

    Niigata, Japan

  • Toho University Omori Medical Center

    RECRUITING

    Ōta-ku, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.